Expression of CD4+T Cells in Myeloproliferative Diseases and the Effect of Ruxolitinib Treatment on Prognosis

Myeloproliferative disorders (MPDs) are rare diseases in which the bone marrow produces too many red, white, or platelets. Myeloproliferative disorders are neither acute nor leukaemia. To study ruxolitinib’s effect on MPD therapy and CD4+ T cell expression. In total, 66 JAK2V617F-positive MPD patien...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Tohoku Journal of Experimental Medicine 2024, Vol.263(4), pp.271-276
Hauptverfasser:	Song, Xiaoying, Dong, Siqi, Yang, Yiping, Zhang, Cong, Sun, Jing, Zhang, Jun, Gao, Lichang, Liu, Jianqiang
Format:	Artikel
Sprache:	eng
Schlagworte:	CD4+ T cells myeloproliferative diseases prognosis ruxolitinib
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!